Magzter GOLDで無制限に

Magzter GOLDで無制限に

10,000以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。

$149.99
 
$74.99/年

試す - 無料

RBI shows easier ECBs but firms may not bite

Mint New Delhi

|

October 29, 2025

ECBs could avert funding stress in Q4, as domestic liquidity has tightened

- Anshika Kayastha & Subhana Shaikh

RBI shows easier ECBs but firms may not bite

The draft seeks easier overseas access, proposing measures like higher per-tranche limits and greater currency flexibility.

(AFP)

Sweeping relaxations by the Reserve Bank of India (RBI) on rules for Indian companies to borrow overseas may not trigger an immediate surge in such loans, as cheaper local loans and high hedging expenses dull the appeal of external commercial borrowings (ECBs).

The central bank earlier this month raised the amount corporates can borrow, scrapped cost caps on external commercial borrowings rates, and eased restrictions on how the funds can be used.

The draft aims to simplify accessing the overseas market, proposing measures like higher per-tranche limits and greater currency flexibility, including the conversion of rupee bonds to foreign currency and vice versa.

External commercial borrowings are foreign-currency or rupee-denominated loans raised from nonresident lenders.

Mint New Delhi からのその他のストーリー

Mint New Delhi

Follow your nose down the bylanes of history

‘The Secret Power of Scent’ takes visitors on a 1,000-year journey

time to read

2 mins

October 30, 2025

Mint New Delhi

Vedanta to boost investment in KCM

Vedanta Resources, the mining and energy company controlled by Indian billionaire Anil Agarwal, proposes to scale up the $1 billion investment in its Zambian copper unit to develop multiple tailing leaching facilities required to enhance copper production from secondary sources, said chief executive officer (CEO) Deshnee Naidoo in an interview.

time to read

1 min

October 30, 2025

Mint New Delhi

BlueStone IPO gets demi-fine jewellery a place in spotlight

A new sparkle BlueStone's blockbuster IPO has boosted investor interest in fashion jewellery startups.

time to read

2 mins

October 30, 2025

Mint New Delhi

Mint New Delhi

CPP targets more growth in India as its portfolio triples

Canada’s CPP Investments expects its India portfolio to grow further after tripling in size over the previous 5 years, top executives at the investment firm said on Wednesday during a media discussion.

time to read

1 mins

October 30, 2025

Mint New Delhi

Shree Cement sticks to its strategy despite slow HI

As large cement makers chase market share, there are concerns over Shree Cement Ltd’s strategy to prioritise a premium pricing over volume.

time to read

1 mins

October 30, 2025

Mint New Delhi

M&As funded by local banks will serve the economy well

Amid the torrent of regulatory notifications from the Reserve Bank of India (RBI) after its last monetary policy meeting, one of the pleasant surprises was its green-lighting of the financing of mergers and acquisitions (M&As) by domestic banks, placing them at par with their global peers.

time to read

3 mins

October 30, 2025

Mint New Delhi

Mint New Delhi

Etsy elevates Kruti Patel Goyal as CEO amid growth slowdown

Online marketplace Etsy Inc. will elevate chief growth officer Kruti Patel Goyal to the CEO job, entrusting the company veteran with navigating the artificial intelligence era and lifting the marketplace out of a post-pandemic slowdown.

time to read

2 mins

October 30, 2025

Mint New Delhi

How freelance editors are driving the creator economy

A new wave of jobs is transforming India’s over ₹3,500 crore creator economy. As social platforms become full-fledged media businesses, freelance editors have become partners for creators and brands alike.

time to read

2 mins

October 30, 2025

Mint New Delhi

Govt preps debt recast plan for discoms

Drugmakers face bans for fake claims as govt set to tweak rules

time to read

2 mins

October 30, 2025

Mint New Delhi

Mint New Delhi

Drugmakers face bans for fake claims as govt set to tweak rules

India plans to enforce strict action against applicants who submit fake or misleading documents to obtain drug licences—a move that could reshape compliance norms in the country’s $50 billion pharmaceutical industry.

time to read

1 mins

October 30, 2025

Listen

Translate

Share

-
+

Change font size